Skip to main content
. Author manuscript; available in PMC: 2021 Jan 1.
Published in final edited form as: Clin Immunol. 2019 Nov 23;210:108317. doi: 10.1016/j.clim.2019.108317

Table 4.

Analysis of Contingency Table: Overview

Table Analyzed P value Odds ratio 95% CI Sensitivity 95% CI Sperifidty 95% CI PPV 95% CI NPV 95%
Aldolase 0.0009 3.741 1.584 to 8.833 92% 0.8340 to 0.9701 25% 0.2081 to 0.2859 16% 0.1238 to 0.1938 95% 0.9000 to 0.9825
Arrestin <.0001 6.509 2.005 to 21.13 95% 0.8671 to 0.9901 25% 0.2086 to 0.2855 14% 0.1055 to 0.1716 98% 0.9325 to 0.9951
CAII 0.0025 2.223 1.309 to 3.778 87% 0.8003 to 0.9181 25% 0.2134 to 0.2983 28% 0.2397 to 0.3256 85% 0.7763 to 0.9075
Enolase <0.0001 5.203 2.981 to 9.083 92% 0.8763 to 0.9547 31% 0.2588 to 0.3560 43% 0.3819 to 0.4762 87% 0.8035 to 0.9262
GADPH 0.0009 3.741 1.584 to 8.833 92% 0.8340 to 0.9701 25% 0.2081 to 0.2859 16% 0.1238 to 0.1938 95% 0.9000 to 0.9825
HSP27 0.0906 5.362 0.7084 to 40.58 95% 0.7397 to 0.9987 23% 0.1950 to 0.2670 4% 0.02437 to 0.06374 99% 0.9569 to 0.9998
p62 <0.0001 10.37 2.503 to 42.93 97% 0.8992 to 0.9965 24% 0.2007 to 0.2749 14% 0.1120 to 0.1771 98% 0.9443 to 0.9981
PKM2 0.122 2.235 0.8592 to 5.812 88% 0.7437 to 0.9602 23% 0.1965 to 0.2704 8% 0.05976 to 0.1138 96% 0.9105 to 0.9871
Tubulin 0.2306 2.274 0.6714 to 7.704 88% 0.6985 to 0.9755 23% 0.1941 to 0.2665 5% 0.03334 to 0.07723 98% 0.9325 to 0.9951